Related Experiment Video
Updated: May 10, 2026
14:03
High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
Published on: March 24, 2023
Technology platform development for targeted plasma metabolites in human heart failure
Cy X'avia Chan1, Anjum A Khan2, Jh Howard Choi1
1NHLBI Proteomics Center at UCLA, Departments of Physiology and Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Clinical Proteomics
|July 6, 2013
Summary
Researchers developed a new workflow to measure heart failure metabolites in plasma. This method improves metabolite detection for potential diagnostic and therapeutic development in heart failure patients.
Area of Science:
- Biochemistry
- Analytical Chemistry
- Cardiovascular Medicine
Background:
- Heart failure is a complex disease with high morbidity and mortality.
- Metabolite alterations are linked to heart failure, but effective assessment technologies are lacking.
- Understanding metabolite contributions requires advanced analytical platforms.
Purpose of the Study:
- To develop and optimize a workflow for targeted plasma metabolite analysis in heart failure.
- To improve the extraction and detection of biologically relevant metabolites.
- To establish a foundation for identifying heart failure biomarkers.
Main Methods:
- Developed a novel workflow combining sample preparation with tandem mass spectrometry.
- Optimized deproteinization, incubation, and reconstitution steps for human plasma.
- Selected 19 metabolites relevant to heart failure pathogenesis.
Main Results:
- Successfully refined a protocol for human plasma metabolite analysis.
- Optimized deproteinization using 20% methanol/ethanol at a 1:3 plasma:solvent ratio.
- Implemented an incubation step that enhanced metabolite signals and peak detection.
- Identified 0.1% formic acid as a superior reconstitution solvent.
- Retrieved 13 out of 19 targeted metabolites from human plasma.
Conclusions:
- Devised a simple and effective workflow for targeted plasma metabolites in heart failure.
- The workflow enables validation and characterization of potential metabolic biomarkers.
- This methodology supports diagnostic and therapeutic development for heart failure.
